Neuroone Medical Technologies (NMTC) Other Non-Current Liabilities (2016 - 2026)

Neuroone Medical Technologies has disclosed Other Non-Current Liabilities across 9 years of filings, most recently posting $709507.0 for Q1 2026.

• Quarterly Other Non-Current Liabilities fell 47.85% year-over-year to $709507.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $709507.0 (down 47.85% YoY) and the FY2025 annual result came in at $1.3 million, down 40.81% from the prior year.
• Other Non-Current Liabilities declined to $709507.0 in Q1 2026, from $806859.0 in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $2.1 million in Q3 2024 and bottomed at $709507.0 in Q1 2026.
• The 3-year median for Other Non-Current Liabilities is $1.3 million (2025), against an average of $1.3 million.
• The widest YoY moves for Other Non-Current Liabilities: up 40.81% in 2025, down 53.92% in 2025.
• Neuroone Medical Technologies' Other Non-Current Liabilities stood at $1.8 million in 2024, then slumped by 53.92% to $806859.0 in 2025, then fell by 12.07% to $709507.0 in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $709507.0, $806859.0, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.